Status:
COMPLETED
Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication
Lead Sponsor:
Kowa Research Institute, Inc.
Conditions:
Intermittent Claudication
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of K-134 for the treatment of intermittent claudication.
Eligibility Criteria
Inclusion
- \- Stable claudication symptoms
Exclusion
- Lower extremity amputation
- Signs or symptoms of critical leg ischemia (CLI)
- Uncontrolled hypertension
- Tachycardia
- Poorly controlled diabetes
- Hypercholesterolemia
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
387 Patients enrolled
Trial Details
Trial ID
NCT00783081
Start Date
November 1 2008
End Date
July 1 2010
Last Update
March 22 2012
Active Locations (42)
Enter a location and click search to find clinical trials sorted by distance.
1
Tucson, Arizona, United States
2
Little Rock, Arkansas, United States
3
Beverly Hills, California, United States
4
Los Angeles, California, United States